Table 3. Logistic regression model comparisons of the nine malignant neoplasms in Taiwan between 2005 and 2009.
Leading malignant neoplasms (ICD code) | P | Description |
Tracheal, bronchial, and lung cancer (ICD 162) | <0.001 | Dissimilaritya |
Liver and intrahepatic bile duct cancer (ICD 155) | 0.253 | Similaritya |
Colon and rectal cancer (ICD 153, 154) | 0.027 | Dissimilaritya |
Stomach cancer (ICD 151) | 0.197 | Similaritya |
Oral cavity cancer (ICD 140, 141, 143–146, 148, 149) | <0.001 | Dissimilaritya |
Esophageal cancer (ICD 150) | <0.001 | Dissimilaritya |
Pancreatic cancer (ICD 157) | 0.217 | Similaritya |
Non-Hodgkin's lymphoma (ICD 200, 202, 203) | 0.009 | Dissimilarity |
Leukemia (ICD 204–208) | 0.760 | Similarity |
a indicates that both compared sides must be Moran's tested clusters.